Skip to content
Broadstreet HEOR
  • What We Do
  • Our Work
  • Who We Are
  • Latest News & Insights
  • Let’s Talk
  • What We Do
  • Our Work
  • Who We Are
  • Latest News & Insights
  • Let’s Talk

Europe’s new health technology assessment era, Part 1: What the JCA means for the pharmaceutical industry

  • Post published: 2 November 2026

What is the JCA? The Joint Clinical Assessment (JCA) is the central component of the EU’s new approach to health technology assessment (HTA), established under Regulation (EU) 2021/2282, creating a…

Continue ReadingEurope’s new health technology assessment era, Part 1: What the JCA means for the pharmaceutical industry

Considering patient preference heterogeneity: insights from psoriasis

  • Post published: 28 October 2026

To acknowledge World Psoriasis Day, we thought we would share some recent research published by Broadstreet’s  Shelagh Szabo, along with Evi Germeni and Neil Hawkins from the University of Glasgow.…

Continue ReadingConsidering patient preference heterogeneity: insights from psoriasis

AI-enhanced SLRs; innovation without compromise

  • Post published: 3 September 2026

Artificial intelligence (AI) is changing evidence synthesis. It offers clear opportunities to accelerate and streamline the way systematic literature reviews (SLRs) are conducted. However, efficiency alone is not enough, evidence…

Continue ReadingAI-enhanced SLRs; innovation without compromise

Creation of a database of case-identifying algorithms developed using Canadian administrative health data

  • Post published: 4 August 2026

At Broadstreet we do a lot of work with real world evidence (RWE), frequently using administrative health data sources. Being able to standardize how cohorts for these types of studies…

Continue ReadingCreation of a database of case-identifying algorithms developed using Canadian administrative health data

MAIC: The Goldilocks of HTA methodology

  • Post published: 24 June 2026

HTA submissions rely heavily on comparisons of treatments, and numerous methodologies have been developed to estimate relative treatment effects across studies in a rigorous fashion. The traditional methods (such as…

Continue ReadingMAIC: The Goldilocks of HTA methodology

Broadstreet at ISPOR 2026 in Philadelphia

  • Post published: 19 May 2026

Broadstreet is pleased to have contributed to seven studies being presented at ISPOR on subjects ranging from patient preferences for chronic obstructive pulmonary disease (COPD) maintenance treatment delivery devices to…

Continue ReadingBroadstreet at ISPOR 2026 in Philadelphia

From Discovery to Therapy: A Century of Phenylketonuria Research

  • Post published: 5 March 2026

Phenylketonuria (PKU) is a rare genetic disorder that causes harmful levels of the dietary protein phenylalanine (Phe), an essential amino acid and a fundamental building block of protein, to build…

Continue ReadingFrom Discovery to Therapy: A Century of Phenylketonuria Research

Patient voices in rare disease health technology assessments (HTA) in Canada

  • Post published: 4 December 2025

Qualitative research can is valuable for its potential to provide in depth insights into complex issues and is particularly valuable for capturing patient perspectives. It can be used to inform…

Continue ReadingPatient voices in rare disease health technology assessments (HTA) in Canada

Broadstreet at ISPOR Europe 2025

  • Post published: 13 November 2025

Broadstreet will be featuring seven of our research projects at ISPOR Europe 2025. Subjects range from health-related quality-of-life in hypophosphatasia to physician perspectives on unmet need and treatment options in…

Continue ReadingBroadstreet at ISPOR Europe 2025

Happy 10th Birthday Broadstreet

  • Post published: 18 September 2025

Continue ReadingHappy 10th Birthday Broadstreet
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Go to the next page
  • What We Do
  • Our Work
  • Who We Are
  • Latest News & Insights
  • Let’s Talk
  • The Broad Street Pump
  • Privacy Policy

info@broadstreetheor.com
300 – 177 West 7th Ave,
Vancouver, BC
Canada, V5Y 1L8
+1 604 800 0648

Follow Us

  • LinkedIn
© 2026 Broadstreet HEOR